PharmChem Inc
OTC:PCHM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
PharmChem Inc
Research & Development
PharmChem Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
PharmChem Inc
OTC:PCHM
|
Research & Development
-$11.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Research & Development
-$364.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
PharmChem Inc
Glance View
PharmChem, Inc. engages in the provision of integrated drug testing services. The company is headquartered in Fort Worth, Texas and currently employs 170 full-time employees. The firm PharmChek Sweat Patch (or Drug Patch) is worn on the skin for up to 10 days and uses sweat as the specimen source. PharmChek kits include PharmChek 50ct. Kit + Standard Panel (N228), PharmChek 50ct. Kit + Standard + Expanded Panel (N229), PharmChek 10ct. Kit + Standard Panel (N225) and PharmChek 10ct. Kit + Standard + Expanded Panel (N226). Its products also include PharmChek Overlay, and PharmChek Analysis Panels, which consist of cocaine, opiates, methamphetamine, amphetamine, marijuana and phencyclidine. Its training modules include construction, storage, wear time, application, removal, shipping and lab screening/confirmation.
See Also
What is PharmChem Inc's Research & Development?
Research & Development
-11.8k
USD
Based on the financial report for Dec 31, 2024, PharmChem Inc's Research & Development amounts to -11.8k USD.
What is PharmChem Inc's Research & Development growth rate?
Research & Development CAGR 1Y
-372%
Over the last year, the Research & Development growth was -372%.
